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INTRODUCTION 
Portal hypertension commonly accompanies the presence of liver 
cirrhosis, and the development of  esophageal varices  is one of the major 
complications of portal hypertension. The prevalence of esophageal varices  in 
patients with liver cirrhosis may range from 60% to 80%, and the reported 
mortality from variceal bleeding ranges from 17% to 57%. Cirrhotic patients 
with Portal Hypertension who  develop esophageal varices  are at a very high 
risk of variceal bleeding and  Variceal rupture is a common cause of death in 
cirrhosis. 
Esophageal varices appear only after the hepatic venous pressure 
gradient (HVPG) has increased to at least 10 to 12 mm Hg.1/3 of 
gastrointestinal bleedings reveal pre-existent cirrhosis. In  patients with 
cirrhosis the incidence of esophageal varices increases by nearly 5% per year, 
and the rate of progression from small to large varices is approximately 5 to 
10 % per year. The risk  of variceal rupture is greatest in the 2 years following 
diagnosis. 
In the 2 years following the first detection of esophageal varices , risk 
of variceal bleeding ranges between 20% to 30% and results in a mortality of 
25% to 50% within a week of the first bleeding episode. Therefore, portal 
hypertensive bleeding prevention remains at the forefront of the long-term 
management of cirrhotic patients. As there is clear evidence that primary 
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prevention of variceal rupture is  cost effective in reducing death rate, 
screening for esophageal varices (EV) is recommended. 
Prophylactic treatment in patients with non selective Beta blockers in 
varices that has never bled appears to decrease the incidence of bleeding by 
40 to 50 % and prolong survival. So  endoscopic screening for varices in 
patients with cirrhosis is desirable, some have suggested this should be 
repeated every other year. 
The  American Association for the Study of Liver Disease single topic 
symposium 1996  stated that cirrhotic patients should be screened for the 
presence of esophageal varices when portal hypertension is diagnosed. 
Recently, the Baveno III Consensus Conference on portal hypertension 
recommended that all cirrhotic patients should be screened for the presence of 
esophageal varices when liver cirrhosis is diagnosed. Other authors have 
suggested repeating endoscopy at 2–3 year intervals in patients without 
varices and at 1–2 year intervals in patients with small varices  and every 
other year in patients  with decompensated  liver disease so as to evaluate the 
development or progression of this feature. 
Endoscopic screening may take place under two circumstances: at the 
initial diagnosis of cirrhosis, since esophageal varices  are an independent 
predictive factor and an early complication of cirrhosis, and during the 
follow-up of patients with cirrhosis without esophageal varices  at risk of 
bleeding at first examination with or without decompensation. 
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It has been estimated that it is only the large esophageal varices (LEV), 
which are associated with a substantially increased risk of variceal bleed. The 
reported incidence of LEV ranges from 9% to 49%. In a recent review, Boyer, 
using a prevalence of LEV of 20%, estimated that a 100 screening endoscopic 
examinations need to be performed to prevent 1 to 2 cases of variceal 
bleeding. 
It is noteworthy however that variceal hemorrhage is not confined to 
patients with large esophageal varices  although they are more likely to bleed 
from ruptured varices than patients with small esophageal varices .  
Cirrhotic patients frequently undergo screening endoscopy for 
the presence of esophageal varices (EV). In the future, this social and medical 
burden will increase due to the greater number of patients with chronic liver 
disease and their improved survival. 
Therefore, the identification of the clinical features that can accurately 
predict LEV and help identify patients at the greatest risk of bleeding is 
quite attractive. This could thus make it possible to identify the 
population with a high probability of LEV that requires confirmation 
by endoscopy, since the regular use of endoscopy is limited due to cost and 
discomfort, resulting in poor compliance. 
The usual clinical practice is to screen all patients with established 
cirrhosis at the time of diagnosis by upper endoscopy for the presence of 
varices. Patients with large varices should be treated with non-selective beta 
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blockers to reduce the incidence of first variceal bleeding. However, fewer 
than 50% of cirrhotic patients have varices at screening endoscopy and most 
have small sized varices, with a low risk of bleeding. 
In order to reduce the increasing burden that endoscopy units will have 
to bear, some studies have attempted to identify characteristics that non-
invasively predict the presence of any esophageal varices or of large 
esophageal varices . These studies have shown that biochemical, clinical, and 
ultrasonographic parameters alone or together have good predictive power for 
non-invasively assessing the presence of esophageal varices . Overall, the 
most common result of these studies was that parameters directly or indirectly 
linked to portal hypertension, such as splenomegaly and decreased platelet 
count, were predictors of the presence of esophageal varices .   
In a study by Thomopoulos et al (2003) seventeen variables considered 
relevant to the presence of esophageal varices were tested and they came to 
the conclusion that Thrombocytopenia, splenomegaly and ascites are 
independent predictors of large esophageal varices in cirrhotic patients.The 
authors suggest that endoscopy could be avoided safely in cirrhotic patients 
with none of these predictive factors, as large varices are absent in this group 
of patients.  
However, in patients with chronic liver disease the presence of 
decreased platelet count may depend on several factors other than portal 
hypertension, such as shortened platelet mean lifetime, decreased 
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thrombopoietin production, or myelotoxic effects of alcohol or hepatitis 
viruses. On the other hand, the presence of splenomegaly in cirrhotic patients 
is likely the result of vascular disturbances that are mainly related to portal 
hypertension. With this in mind, according to Gianni et al(2003) , their  study  
used the platelet count/spleen diameter ratio as a parameter linking 
thrombocytopenia to spleen size in order to introduce a variable that takes into 
consideration the decrease in platelet count, which most likely depends on 
hypersplenism. 
According to Gianni et al (2003) use of the platelet count/spleen 
diameter ratio would have avoided performing unnecessary endoscopies in all 
patients with a cut off >909 without running the risk of not diagnosing 
esophageal varices   
Analysis of patients with compensated disease was of particular 
importance. In fact, predicting the presence of esophageal varices  in patients 
with no signs of decompensation could be especially useful and its clinical 
importance has recently been emphasised.They observed that even among 
patients with compensated disease, platelet count/spleen diameter ratios were 
significantly different between those  without esophageal varices  and  those 
with esophageal varices , and the platelet count/spleen diameter ratio had the 
highest accuracy for identifying patients with esophageal varices .  
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Most importantly, this parameter proved to be independent of the 
Child-Pugh classification allowing a more confident use even in patients with 
compensated disease. 
In many studies Serum ascitic albumin gradient (SAAG) was found to 
be an independent predictor of portal hypertension and Esophageal varices 
especially in alcoholic cirrhosis . The serum-ascites albumin (SAA) gradient 
has been defined as the serum albumin concentration minus the ascitic fluid 
albumin concentration. The SAA gradient is superior to the exudate-
transudate concept to classify ascites, being a exact portal hypertension (PH) 
marker. An elevated SAA gradient (1.1 g/L or greater) correlates with Portal 
Hypertension, whereas a low gradient indicates no Portal Hypertension. Thus 
the  SAA gradient correlates well with Portal Hypertension in cirrhotic 
patients. 
To propose that portal hypertension exists by the serum-ascites 
albumin gradient (SAAG) possesses a validity rate of 96.7% in the adult 
population.(Demyrel et al 2003). 
In several studies recently carried out, it was emphasized that serum-
ascites albumin gradient (SAAG) based on the difference between the 
albumin levels of serum and ascites fluid should be used to determine the 
etiology of the ascites cases instead of discrimination between transudate and 
exudate. It was shown that such a classification has a validity rate of 90% or 
more in detecting the ascites of portal hypertension. 
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In several studies on cirrhosis due to alcohol, the correlation between 
SAAG and esophageal varices was emphasized and additionally, SAAG was 
proposed to be a factor determining the degree of portal hypertension and the 
prognosis in patients with cirrhosis due to alcohol.There are scant studies in 
the literature to evaluate SAAG and esophageal varices in the patients with 
non-alcoholic cirrhosis. When the value of SAAG was more than 2 , strong 
correlation existed even in Non alcoholic cirrhosis. 
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AIMS AND OBJECTIVES 
 
 
1. To identify non invasive parameters for prediction of esophageal 
varices  in newly diagnosed patients with cirrhosis. 
2. To assess the Predictive value of Platelet count/ splenic diameter ratio 
in predicting esophageal varices  in cirrhotic patients. 
3. To assess the usefulness  of SAAG(Serum ascitic albumin gradient) in 
predicting esophageal varices in patients with cirrhosis. 
4. To assess the predictive value of combining two parameters; Platelet 
count/ splenic diameter ratio and Serum ascitic albumin gradient ( 
SAAG) in patients with decompensated liver disease presenting as 
ascites. 
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REVIEW OF LITERATURE 
Cirrhosis is a pathologically defined entity  that is associated with a 
spectrum of clinical manifestations.(34)    
Definition 
Cirrhosis is defined anatomically as a diffuse process with fibrosis and 
nodule formation. Although the causes are many, the end results are the 
same.59 
Evolution of cirrhosis (34) 
The cardinal pathological features reflect irreversible chronic injury of 
the hepatic parenchyma and include extensive fibrosis in association with 
formation of regenerative nodules. These features result from hepatocyte 
necrosis, collapse of supporting reticulin network with subsequent connective 
tissue deposition, distortion of vascular bed, and nodular regeneration of 
remaining liver parenchyma. The pathologic process should be viewed as a 
final common pathway of many types of chronic liver injury. Clinical features 
of cirrhosis derive from the morphological alterations and often reflect the 
severity of hepatic damage rather than the etiology of the underlying liver 
disease. Loss of functioning hepatocellular mass may lead to jaundice, edema, 
coagulopathy, and a variety of metabolic abnormalities; fibrosis and distorted 
vasculature lead to portal hypertension and its sequelae, including gastro 
esophageal varices and splenomegaly. Ascites and hepatic encephalopathy 
result from both hepatocellular insufficiency and portal hypertension.  
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Classification of cirrhosis(59) 
Three anatomical types of cirrhosis are recognized; micro nodular, 
macro nodular and mixed. Micro nodular cirrhosis is characterized by thick 
regular septae, by regenerating small nodules varying little in size, and by 
involvement of every lobule. The macro nodular liver may represent impaired 
capacity for regrowth as in alcoholism, malnutrition, old age or anemia. 
Regeneration in a micro nodular cirrhosis results in a macronodular or 
mixed appearance. With time, micronodular cirrhosis often converts 
to macronodular. 
Aetiology: 
1. Alcohol. 
2. Viral hepatitis types B ± delta; C.. 
3. Metabolic, e.g. haemochromatosis, Wilson's disease, α1 antitrypsin 
deficiency, type IV glycogenosis, galactosaemia, congenital tyrosinosis  
and non-alcoholic steatohepatitis. 
4. Prolonged cholestasis, intra-and extra-hepatic. 
5. Hepatic venous outflow obstruction, e.g. venoocclusive disease, Budd-
Chiari syndrome, constrictive pericarditis. 
6. Disturbed immunity (autoimmune hepatitis). 
7. Toxins and therapeutic agents, e.g. methotrexate, amiodarone. 
8. Indian childhood cirrhosis. 
9. Cryptogenic cirrhosis. 
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Diagnosis of cirrhosis 
A) Clinical history (34,58,59) 
Fatigue and weight loss, loss of libido, anorexia and 
flatulent dyspepsia, abdominal pain, Jaundice, colour of urine and faeces, 
swelling of legs or abdomen, hemorrhage - nose, gums, skin, alimentary tract. 
Past health: jaundice, hepatitis, drugs ingested,  blood  transfusion.  Social: 
 alcohol  consumption. 
B) Examination: 
Nutrition, fever, fetor hepaticus, jaundice, pigmentation, purpura, 
finger clubbing, white nails, vascular spiders, palmar erythema, 
gynaecomastia, testicular atrophy, distribution of body hair. 
Abdomen: ascites, abdominal wall veins, liver, spleen, edema 
Neurological changes: mental functions, stupor, and tremor 
C)Investigations : 
Haematology 
• Hemoglobin 
• Leukocyte count 
• Platelet count 
• Prothrombin time 
Serum biochemistry 
• Bilirubin 
• Transaminases Immunoglobulins 
• Alkaline phosphatase 
• γ - Glutamyl transpeptidase 
• Albumin and globulin 
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If ascites present 
• Serum electrolytes. 
• Daily weight. 
• Urea and creatinine. 
• 24 hours urinary volume and sodium. 
• SAAG 
Serum immunological investigations 
• Hepatitis B Ag, Anti HCV. 
• Alpha-fetoprotein. 
• Smooth muscle, mitochondrial, nuclear antibodies. 
Hepatic CT scan or ultrasound : 
Using ultrasound, cirrhosis is suggested by line surface nodularity and 
portal vein mean flow velocity. The caudate lobe is enlarged relative to the 
right lobe. Regeneration nodules may be shown as focal lesions. CT scan is 
cost-effective for the diagnosis of cirrhosis and its complications. Liver size 
can be assessed and the irregular nodular surface seen. After intravenous 
contrast, the portal vein and hepatic veins can be identified in the liver, and a 
collateral circulation with splenomegaly may give confirmation to the 
diagnosis of portal hypertension. Ascites can be seen. 
Liver biopsy : 
Biopsy diagnosis of cirrhosis may be difficult. Reticulin and collagen 
stains are essential for the demonstration of a rim of fibrosis around the 
nodule. 
EEG :EEG is indicated if neuropsychiatric changes are present and to detect 
early changes in pre-coma. 
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Compensated cirrhosis (59) 
The disease may be discovered at a routine examination or biochemical 
screen, or at operation undertaken for some other condition. Cirrhosis may be 
suspected if the patient has mild pyrexia, vascular spiders, palmar erythema, 
or unexplained epistaxis or edema of the ankles. Firm enlargement of the liver 
and splenomegaly are helpful diagnostic signs.  
Vague morning indigestion and flatulent dyspepsia may be early 
features in the alcoholic cirrhotic. Confirmation should be sought by 
biochemical tests, scanning and if necessary, by liver biopsy. Biochemical 
tests may be quite normal in this group. The most frequent changes are a 
slight increase in the serum transaminase or γ-GT level. Diagnosis is 
confirmed by needle liver biopsy. 
Decompensated cirrhosis 
The patient usually seeks medical advice because of ascites and or 
jaundice. General health fails with weakness, muscle wasting and weight loss. 
Continuous mild fever (37.5-38°C) is often due to gram-negative 
bacteraemia, to continuing hepatic cell necrosis or to liver cell carcinoma. A 
liver flap may be present. The deeper the jaundice, the greater the liver cell 
dysfunction. 
Pigmentation of the skin and clubbing of the fingers are occasionally 
seen. Purpura over the arms, shoulders and shins may be associated with a 
low platelet count. Spontaneous bruising and epistaxis reflect a prothrombin 
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deficiency. The blood pressure is low. Sparse body hair, vascular spiders, 
palmar erythema, white nails and gonadal atrophy are common. Ascites and 
edema of the legs is frequently associated. The liver may be enlarged (early 
stages), with a regular edge, or contracted and impalpable (late stages). 
The spleen may be palpable.(59) 
Child - Pugh classification (18,34,58,59) 
CHILD PUGH CLASSIFICATION 
 A B C 
S. Bilirubin <2.0 2-3 >3 
S. Albumin >3.5 2.8-3.5 <2.8 
Ascites None Slight or Controlled Moderate or 
Uncontrolled 
Encephalopathy None Minimal Coma 
ProthrombinTime(sec) 
Or INR 
0-4 
<1.7 
4-6 
1.7-2.3 
>6 
>2.3 
 
The total score classifies patients into grade A (5-7) B(7-9) 
or C(>10). Poor prognosis is associated with a prolonged prothrombin time, 
marked ascites, gastrointestinal bleeding, advanced age, high daily alcohol 
consumption, high serum bilirubin and alkaline phosphatase, low albumin 
values, and poor nutrition.  
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Patients with compensated cirrhosis become decompensated at the rate 
of 10% per year. Ascites is the usual first sign. Decompensated patients have 
around a 20% 5-year survival.(34,58,59) 
According to Madhotra et al( 2002) (42)  and Zaman et al(2001)(64) the 
prevalence of esophageal varices  in cirrhosis increases with severity of liver 
disease, as assessed by Child Pugh Classification. 
The following points are useful prognostically: 
• Liver Size. A large liver carries a better prognosis than a small one 
because it is likely to contain more functioning cells. 
• Hemorrhage from oesophageal varices. If liver function is good, 
hemorrhage may be tolerated; if poor, hepatic coma and death are 
probable. 
• Persistent hypotension (systolic BP<100 mmHg) is serious. 
• Ascites worsens the prognosis. 
• If decompensation has followed hemorrhage, infection or alcoholism, 
the prognosis is better than if it is spontaneous, because the 
precipitating factor is correctable. 
• Jaundice, especially if persistent, is a serious sign 
• Neurological complication. The significance of encephalopathy 
depends on the clinical circumstances. Developing in the course of 
progressive hepato-cellular failure, it carries a bad prognosis. Chronic 
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and those with an extensive portal systemic collateral circulation who 
respond well to medical treatment carry good prognosis. 
• Biochemical tests. If the serum albumin is less than 25g/L the outlook 
is poor. Hyponatraemia (serum sodium<120mmol/L), if unrelated to 
diuretic therapy, is grave. Serum transaminase and globulin levels give 
no guide to prognosis. 
• Alcoholic cirrhotics, if they abstain, respond better than those with 
'cryptogenic' cirrhosis 
• The response to therapy. If the patient has failed to improve within 1 
month of starting hospital treatment, the outlook is poor. 
• Hepatic histological changes. Sections are useful in evaluating the 
extent of necrosis and of inflammatory infiltration. A fatty liver 
responds well to treatment. 
PORTAL HYPERTENSION 
ANATOMY OF PORTAL VENOUS SYSTEM(59) 
Portal system includes all veins that carry blood from the alimentary 
tract, the spleen, pancreas and gall bladder. Portal vein is formed by union of 
superior mesenteric vein and splenic vein just posterior to the head of 
pancreas and it enters the liver at the porta hepatis and it divides into two 
main branches, one to each lobe. Portal blood flow in man is 1000-
1200mL/min. Portal pressure is about 5-10  mm Hg. 
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COLLATERALS 
Abdominal wall veins 
Prominent collateral veins radiating from umbilicus are termed caput 
medusae. This is rare and usually only one or two veins, frequently epigastric, 
are seen. The blood flows away from umbilicus. 
VARICES 
Esophageal: 
The major blood supply to oesophageal varices is the left gastric vein. 
The posterior branch usually drains into the azygos stem, whereas the anterior 
branch communicates with varices just below the oesophageal junction and 
forms a bundle of thin parallel veins that run in the junction area and 
continues in large tortuous veins in the lower esophagus. Intraepithelial veins 
may correlate with red spots seen on endoscopy and predict variceal rupture. 
The superficial venous plexus drains into larger, deep intrinsic 
veins. Perforating veins connect the deeper veins with the fourth layer 
of adventitial plexus. Typical large varices arise from the main trunks of deep 
intrinsic veins and these communicate with gastric varices. 
Gastric 
These are largely supplied by short gastric veins and drain into 
the deep intrinsic veins of oesophagus. They are particularly prominent 
in patients with extra hepatic portal hypertension. 
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Colo - rectal 
These develop secondary to inferior mesenteric - internal iliac venous 
collaterals. They are visualized by colonoscopy. Collaterals between the 
superior haemorrhoidal (portal) veins and the middle and inferior 
haemorrhoidal (systemic) veins lead to anorectal varices. 
Portal hypertensive gastropathy 
This is almost always associated with cirrhosis and is seen in 
the fundus and body of the stomach. Histology shows vascular ectasia 
in mucosa. These gastric changes may be increased after sclerotherapy. 
HAEMODYNAMICS OF PORTAL HYPERTENSION 
The fundamental haemodynamic abnormality is an increased resistance 
to portal flow. This may be mechanical due to the disturbed architecture and 
nodularity of cirrhosis or due to obstructed portal vein.. Splanchnic 
vasodilatation is probably the most important factor in maintaining the hyper 
dynamic circulation. The increased portal flow raises the oesophageal variceal 
transmural pressure. There seems to be interplay of vasodilators and 
vasoconstrictors. These might be formed by the hepatocyte, fail to be 
inactivated by it or be of gut origin and pass through intrahepatic or 
extrahepatic venous shunt. 
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CLASSIFICATION AND CAUSES OF PORTAL HYPERTENSION (58) 
I ) Primary increased flow 
1.Arterioportal venous fistula. 2 Splenic capillary hemangiomatosis. 
II ) Primary increased resistance 
1. Prehepatic: 1.Thrombosis/ cavernous transformation of the 
portal vein 2.Splenic vein thrombosis. 
2. Intrahepatic :1.)Presinusoidal – Schistosomiasis, Sarcoidosis, 
Myeloproliferative diseases/ myelofibrosis, Congenital hepatic fibrosis, 
Idiopathic portal hypertension, Chronic arsenic hepatotoxicity, Vinyl chloride 
hepatotoxicity,Early primary biliary cirrhosis, Early primary sclerosing 
cholangitis. 2) Sinusoidal / mixed – cirrhosis secondary to chronic hepatitis, 
Cryptogenic cirrhosis, Methotrexate, Alcoholic hepatitis, Hypervitaminosis A, 
Incomplete septal fibrosis, Nodular regenerative hyperplasia. 3) Post 
sinusoidal – Veno-occlusive disease, Hepatic vein thrombosis(Budd-Chiari 
syndrome). 4) Post hepatic – Inferior venacaval web, Constrictive pericarditis, 
Tricuspid insufficiency, severe right heart failure. 
 
CLINICAL FEATURES OF PORTAL HYPERTENSION( 18,34,58,59) 
History  a.) alcoholism b) jaundice c) melena d) hematemesis  
General examination. 
 20
Stigmata of liver disease: The stigmata of cirrhosis include vascular 
spiders, palmar erythema, anemia, and ascites. Precoma should be excluded. 
Other features: hepatomegaly, venous hums, abdominal wall veins 
Spleen : 
The spleen (firm) enlarges progressively. It may be mild to moderate in 
size. Size bears little relation to the portal pressure. An enlarged spleen is the 
single most important diagnostic sign of portal hypertension. Massive 
splenomegaly is associated with pancytopenia. (secondary hypersplenism). 
Ascites: 
The portal hypertension raises the capillary filtration pressure, and 
determines fluid localization to the peritoneal cavity. Ascites in cirrhosis 
always indicates liver cell failure in addition to portal hypertension. In 
cirrhosis, the serum albumin concentration is usually at least 1gm/dL higher 
than that of the ascitic fluid, thus resulting in a high serum - ascites albumin 
gradient >/=l.l gm/dL reflecting indirectly the abnormally high hydrostatic 
pressure gradient between the portal bed and the ascitic compartment. 
Conversely presence of a low SAAG (< 1.1 gm/dl) will usually exclude 
cirrhosis and portal hypertension. 
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INVESTIGATIONS 
Endoscopy  
The size of varix must be graded (59) 
• Grade 1 (Fl): the varices can be depressed by the endoscope 
• Grade 2 (F2): the varices cannot be depressed by the endoscope 
• Grade 3 (F3) the varices are confluent around the 
circumference of the oesophagus. 
CONN'S GRADING (59) 
• Grade I - small varices detectable on valsalva only 
• Grade II -1-3 mm varix- in both phases of respiration 
• Grade III - 3-6 mm varices, not occluding the lumen 
• Grade IV - >6mm varices, occluding the lumen 
Larger the varix, the chances of bleeding is more. Varices usually 
appear white and opaque. Dilated sub epithelial veins may appear as raised 
cherry red spots and red whale markings. The haemocystic spot is 
approximately 4mm in diameter. It represents blood coming from deeper 
extrinsic veins of oesophagus straight out towards the lumen through a 
communicating vein into the more superficial submucosal veins. Red colour 
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is usually associated with larger varices. All these colour changes 
and particularly the red colour sign predict variceal bleeding. 
Portal hypertensive gastropathy is seen largely in the fundus. It is seen as a 
mosaic like pattern. Variceal (azygos) blood flow can be assessed during 
diagnostic endoscopy by a Doppler US probe passed down the biopsy channel 
of the standard gastroscopy. 
Imaging the portal venous system( 18,34,58,59) 
Ultrasound: 
A large portal vein suggests portal hypertension. If collaterals are seen, 
this confirms portal hypertension. 
Doppler ultrasound 
Doppler US demonstrates the anatomy of the portal veins and hepatic 
artery. Doppler US shows spontaneous hepato-fugal flow in portal, splenic 
and superior mesenteric veins in patients with cirrhosis. Variceal bleeding is 
more likely if the flow is hepatopetal. Colour Doppler is a good way of 
demonstrating portal systemic shunts and the direction of flow in them. 
Duplex Doppler has-been used to measure portal blood flow. In 
cirrhosis, the portal vein velocity tends to fall and when less than 6cm/s portal 
hypertension is likely. 
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C.T scan 
After contrast, portal vein patency can be established and esophageal 
varices may be shown as intraluminal protrusions enhancing after 
contrast. Gastric varices show as rounded structures, indistinguishable from 
the gastric wall. 
In cirrhosis, the venogram varies widely. It may be completely normal 
or may show filling of large numbers of collateral vessels with gross 
distortion of the intra-hepatic pattern ('tree in winter appearance). 
Portal pressure measurement 
A balloon catheter is introduced into the femoral vein and, under 
fluoroscopic control, into the hepatic vein. Measurements taken in the wedged 
hepatic venous pressure (WHVP) and free hepatic venous pressure (FHVP) 
positions by inflating and deflating the balloon in the tip of the catheter. The 
hepatic venous pressure gradient (HVPG) is the difference between WHVP 
and FHVP. This is the portal (sinusoidal) venous pressure. The normal HVPG 
is 5-6 mm Hg and values of about 20mmHg are found in patients with 
cirrhosis. HVPG may relate to survival and also to prognosis in patients with 
bleeding oesophageal varices. Its value in the prediction of variceal bleeding 
is uncertain.(34,59) 
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Variceal pressure: 
An endoscopic pressure gauge may be fixed to the end of 
the endoscope. The level of venous pressure is a major factor predicting 
variceal hemorrhage. 
BLEEDING OESOPHAGEAL VARICES (59) 
Predicting rupture 
Sixty five per cent of cirrhotic patients with varices will not bleed 
within 2 years of diagnosis, but 50% will die of the first hemorrhage. There is 
a strong correlation between variceal size assessed endoscopically, and the 
probability of bleeding. Intravariceal pressure is less important, although a 
portal pressure above 12 mmHg appears necessary for varices to form and 
subsequently bleed. 'Red spots', danger signs seen at endoscopy, are 
valuable indictors of imminent hemorrhage. Child's grade is used to assess 
hepato-cellular function. It is the most important predictor of the likelihood of 
bleeding. It correlates with variceal size, with the presence of endoscopic 
red signs and with the response to treatment. 
These three variables - size, presence of red signs and hepatocellular 
function-are the best predictors of bleeding. Patients with alcoholic cirrhosis 
may be at the most risk. Doppler sonography predicts the likelihood of 
bleeding. This is based on velocity and diameter of the portal vein, spleen 
size and the presence of collaterals. 
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Prevention of bleeding 
Liver function must be improved, for instance, by abstaining from 
alcohol. Aspirin and NSAIDs should be avoided. Propranolol is a non-
selective β-blocker, which reduces portal pressure by splanchnic vaso-
constriction and, to a lesser extent, by reducing cardiac output. The drug is 
given in a dose, which reduces the resting pulse rate by 25% 12h after intake. 
The portal pressure must be maintained at 12mm Hg or lower. Propranolol 
is recommended for those with large varices and with red endoscopic danger 
signs. Patients with an HVPG greater than 12mmHg should be treated 
whatever the size of the varices. Nadolol gives equivalent results. Isosorbide-
5 mononitrate is equally effective in prophylaxis of the first bleed, but the 
probability of death is significantly greater, particularly in those more than 50 
years old. The addition of nitrate to β-blocker should be reserved for 
those failing therapy with the β-blocker alone. Variceal sclerotherapy or 
ligation is not so satisfactory or cost effective as vaso-active active drugs. 
Diagnosis of bleeding 
The clinical features are those of gastro intestinal bleeding with the 
added picture of portal hypertension. Endoscopy is performed routinely to 
confirm the source of the bleeding. 
Prognosis(59) 
Between 30 and 50% will die within 6 weeks of the first bleed. The 
prognosis is determined by the severity of the hepato-cellular disease. The 
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ominous triad of jaundice, ascites and encephalopathy is associated with 80% 
mortality. The 1-year survival in good-risk (Child grade A and B) patients is 
about 85% and in bad - risk (Child grade C) patients about 30%. 
Alcoholics have a worse prognosis, as hepatocellular disease is greater. 
Abstinence from alcohol considerably improves the prognosis. A low portal 
blood velocity by Doppler predicts shorter survival. 
As liver biopsy is invasive there has been a lot of interest in the ability 
to detect cirrhosis by non invasive means, such as sonography. 
THE SONOGRAPHIC PATTERNS ASSOCIATED WITH  
CIRRHOSIS (34,59) 
• Volume redistribution Several studies have evaluated the ratio of the 
caudate lobe width to the right lobe width (C/RL) as an indicator of 
cirrhosis. A C/RL value of 0.65 is considered indicative of cirrhosis. 
• Coarse echotexture 
Increased echogenicity and coarse echotexture are frequent 
observations in diffuse liver disease 
• Nodular surface 
The nodularity corresponds to the presence of regenerating nodules and 
fibrosis.  
• Regenerating nodules 
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Regenerating nodulesrepresent regenerating hepatocytes surrounded by 
a fibrotic septa.  
• Dysplastic nodules 
Dysplastic nodules or adenomatous hyperplastic nodules are larger 
than regenerating nodules (diameter ≥ 10 mm) and are considered 
premalignant. 
DOPPLER CHARACTERISTICS OF CIRRHOSIS(58,59) 
The normal Doppler wave form of the hepatic veins reflects the 
hemodynamics of the right atrium. The waveform is triphasic: two large 
antegradediastolic and systolic waves and a small retrograde wave 
corresponding to the atrial “kick”. Because the walls of the hepatic veins are 
thin, disease of the hepatic parenchyma may alter their compliance. In many 
patients with compensated cirrhosis (no portal hypertension), the Doppler 
waveform is abnormal. Two abnormal patterns have been described; 
decreased amplitude of phasic alterations with reversal of flow; and a 
flattened waveform. These abnormal patterns have also been found in patients 
with fatty infiltration of their livers. 
 As cirrhosis progresses, luminal narrowing of the hepatic veins 
may be associated with flow alterations visible on colour and spectral 
Doppler. High velocity signals through an area of narrowing produce colour 
aliasing and turbulence. 
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The hepatic artery waveform also shows altered flow dynamics in 
cirrhosis and chronic liver disease. The vasoconstriction of the hepatic artery 
occurs as a normal response to the increased portal venous flow stimulated by 
eating (≥ 20%). In patients with cirrhosis and chronic liver disease, the normal 
increase in postprandial resistive index is blunted. 
SONOGRAPHIC FINDINGS IN PORTAL HYPERTENSION 
They include the secondary signs of splenomegaly, ascites and 
portosystemic venous collaterals. When the resistance to blood flow in the 
portal vein exceeds the resistance to flow in small communicating channels 
between the portal and systemic circulations, portosystemic collaterals form. 
Thus although the caliber of portal vein may initially be increased (≥ 1.3 cm) 
in portal hypertension, with the development of portosystemic shunts, the 
portal vein caliber will decrease in size. Five major sites of collaterals are 
visualized by ultrasound. 
• Gastroesophageal junction – Between the coronary and short 
gastric veins and the systemic esophageal veins. Dilatation of coronary veins 
(0.7) is associated with severe portal hypertension (portohepatic gradient >10 
mm Hg). 
• Paraumbilical vein – Runs in the falciform ligament and 
connects the left portal vein to the systemic epigastric veins near the 
umbilicus (Cruveilhier – Baumgarten syndrome). Several authors have 
suggested that, if the hepatofugal flow in the patent paraumbilical vein 
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exceeds the hepatopetal flow in the portal vein, patients may be protected 
from developing esophageal varices. 
 
• Splenorenal and gastro renal – Tortuous veins may be seen in 
the region of the splenic and left renal hilus, which represent collaterals 
between splenic, coronary and short gastric veins and the left adrenal or renal 
veins. 
• Intestinal – Regions in which the gastrointestinal tract becomes 
retroperitoneal so that the veins of the ascending and descending colon, 
duodenum, pancreas and liver may anastomose with the renal, phrenic and 
lumbar veins. 
• Hemorrhoidal – The perianal region were the superior rectal 
veins, which extend from the inferior mesenteric vein, anastomose with the 
systemic middle and inferior rectal veins. 
Duplex doler sonography provides additional information regarding 
direction of portal flow. False results may occur, however when sampling is 
obtained from periportal collaterals in patients with portal vein thrombosis or 
hepatofugal portal flow. Normal portal venous flow rates will vary in the 
same individual, increasing postprandially and during inspiration and 
decreasing following exercise or when the patient is in upright position. An 
increase of less than 20% in in the diameter of the portal vein with 
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deepinspiration indicates portal hypertension with 81% sensitivity and 100% 
specificity. 
 
The normal portal vein demonstrates an undulating hepatopetal flow. 
Mean portal flow velocity is approximately 15 to18 cm/sec and varies with 
respiration and cardiac pulsation. As portal hypertension develops the flow in 
the portal vein loses its undulatory pattern and becomes monophasic. As the 
severity of the portal hypertension increases, flow becomes biphasic and 
finally hepatofugal. Intravenous arterial – portal venous shunting may also be 
seen. 
Chronic liver disease is also associated with increases splanchnic blood 
flow. Recent evidence suggest that portal hypertension is in part caused by the 
hyperdynamic flow state of cirrhosis.(36) 
The limitations of Doppler sonography in the evaluation of portal 
hypertension include the ability to accurately determine vascular pressure and 
flow rates. Patients with portal hypertension are often ill with contracted 
livers, abundant ascites and floating bowel, all of which are a technical 
challenge. On comparing duplex Doppler with MR angiography, MR imaging 
was superior in the assessment of patency of the portal vein and surgical 
shunts as well as in detection of varices. However when the Doppler is 
technically adequate, it was accurate in the assessment of normal portal 
anatomy and flow direction. Duplex doppler sonography has the added 
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advantages of decreased cost and portability of the equipment and therefore 
should be used as an initial screening method for portal hypertension. 
 
NON INVASIVE PARAMETERS FOR PREDICTION OF 
ESOPHAGEAL VARICES 
Studies have attempted to identify characteristics that non-invasively 
predict the presence of any esophageal varices  or of large esophageal  
varices.(7,12,22,24,26,27,28,3642,46,47,50) These studies have shown that biochemical, 
clinical, and ultrasonographic parameters alone or together have good 
predictive power for non-invasively assessing the presence of esophageal 
varices. .Overall, the most common result of these studies was that parameters 
directly or indirectly linked to portal hypertension, such as splenomegaly and 
decreased platelet count, were predictors of the presence of esophageal 
varices(26,56,60,64,65) 
In a study by Thomopolos et al (2003)(60) seventeen variables 
considered relevant to the presence of esophageal varices were tested and they 
came to the conclusion that Thrombocytopenia, splenomegaly and ascites are 
independent predictors of large esophageal varices in cirrhotic patients. 
 In a study performed by Hoefs et al(1983)(35), it was shown that an 
excellent correlation exists between portal hypertension and Serum- ascitic 
albumin gradient (SAAG). 
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CHRONIC LIVER DISEASE AND PLATELET COUNT 
Abnormalities in platelet count and function are common in patients 
with all forms of liver disease. In patients with chronic liver disease and portal 
hypertension, a low platelet count is due in part to increased splenic 
sequestration and to low thrombopoietin levels, the key regulator of platelet 
function produced mainly by liver. Decreased production of platelets from the 
bone marrow follows alcohol excess, folic acid deficiency and viral hepatitis. 
Platelet function, in particular aggregation, is impaired in patients with 
cirrhosis, particularly Child's grade C, due to an intrinsic defect and 
circulating serum factors. There is reduced availability of arachidonic acid for 
prostaglandin production, and also a reduction in platelet adenosine 
triphosphate and 5-hydroxytryptamine. Abnormal platelet aggregation due to 
disseminated intravascular coagulation may be an additional important factor 
in severe liver failure. 
The thrombocytopenia of chronic liver disease (usually 60-90 X 109/L) 
is extremely frequent and is largely due to hypersplenism.(23,26,34,49,58,59) 
Several studies have assessed the role of platelet count in predicting 
esophageal varices. 
According to Pilette et al (1999)(50) in patients with cirrhosis, the 
diagnostic accuracy of platelet count (<1,60,000) for large varices provided a 
sensitivity of 80% and a specificity of 58% and a platelet count of ≥2,60,000 
has a negative predictive value of ≥ 91%.  
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According to Schepis et al(2001).(57) a platelet count less than 100 x 
109/L was found to be having a role in predicting esophageal varices . 
 Platelet count of < 68000/cubic mm had a specificity of 73% in 
predicting esophageal varices as reported by Madhotra et al.(2002)(42) 
Zaman et al (1999) found that  a platelet count of 90 x 103/µL or less 
had a role in predicting varices. (65) 
Study by Ng  et al(1999) reported that  the optimal critical value for the 
platelet count was 150 x 109/L, of patients without thrombocytopenia and 
ascites. (46) 
SPLENOMEGALY 
According to study by Chalasani et al.(1999)(7) splenomegaly and low 
platelet count were independent predictors of large esophageal varices. On the 
basis of these variables, cirrhotics were stratified into high risk groups for the 
presence of large esophageal varices. Patients with platelet count of ≥ 
88,000/cu mm and no splenomegaly by physical examination had a risk of 
large esophageal varices of 7.2%. Those with splenomegaly or platelet count 
< 88,000/cu mm had a risk of large esophageal varices . Their data showed 
that clinical predictors could be used to stratify cirrhotic patients for the risk 
of rupture of large esophageal varices and such stratification could be used to 
improve the cost effectiveness of screening endoscopy. 
Thomopolos et al(2003) have reported splenomegaly as an independent 
predictor of esophageal varices in cirrhotic patients.(60) 
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 Torres et al (1996) investigated the association and correlation 
between ultrasonographic parameters of portal hypertension  and the presence 
and level of portal hypertension (determinate by the serum-to-ascites albumin 
concentration gradient). They demonstrated that ultrasonographic 
splenomegaly studied by longitudinal diameter of the spleen discriminate 
patients with portal hypertension with a high positive predictive value 
(94.4%), although it didn't happen with transverse diameter of the spleen.(63) 
According to Chalasani et al (1999) .(7) splenomegaly detected by 
computed tomographic scan (odds ratio: 4.3; 95% confidence interval: 1.6-
11.5) or by physical examination (odds ratio: 2.0; 95% confidence interval: 
1.1-3.8), and low platelet count were independent predictors of large 
esophageal varices. On the basis of these variables, cirrhotics were stratified 
into high- and low-risk groups for the presence of large esophageal varices. 
Patients with a platelet count of > or = 88,000/mm3 (median value) and no 
splenomegaly by physical examination had a risk of large esophageal varices 
of 7.2%. Those with splenomegaly or platelet count < 88,000/mm3 had a risk 
of large esophageal varices of 28% (p < 0.0001). The authors conclude  that 
clinical predictors could be used to stratify cirrhotic patients for the risk of 
large esophageal varices. 
According to Sanjay Kumar Sharma et al (2006) .(56) presence of 
palpable spleen and low platelet count are independent predictors of presence 
of large esophageal varices  in patients with cirrhosis. Use of these parameters 
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may help identify patients with a low probability of large esophageal varices  
who may not need endoscopy. This may help reduce costs and discomfort for 
these patients and the burden on endoscopy units. 
 
RELEVANCE OF PLATELET COUNT/SPLENIC DIAMETER RATIO 
Gianni et al(2003)(26)  proposed platelet count/ splenic diameter ratio as 
a non invasive marker for predicting esophageal varices  in patients with  liver 
cirrhosis. Parameters directly or indirectly linked to portal hypertension, such 
as splenomegaly and decreased platelet count, were predictors of the presence 
of esophageal varices . However, in patients with chronic liver disease the 
presence of decreased platelet count may depend on several factors other than 
portal hypertension, such as shortened platelet mean lifetime, decreased 
thrombopoietin production, or myelotoxic effects of alcohol or hepatitis 
viruses. On the other hand, the presence of splenomegaly in cirrhotic patients 
is likely the result of vascular disturbances that are mainly related to portal 
hypertension. With this in mind,  the  study  used the platelet count/spleen 
diameter ratio as a parameter linking thrombocytopenia to spleen size in order 
to introduce a variable that takes into consideration the decrease in platelet 
count which most likely depends on hypersplenism caused by portal 
hypertension.  
In the study Maximum spleen bipolar diameter was estimated by means 
of ultrasound scan and was expressed in millimetres (mm). Platelet 
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count/spleen diameter ratio of all patients was calculated. They found that 
Spleen diameter was higher while platelet count/spleen diameter ratio was 
lower in patients with esophageal varices . Receiver operating characteristic 
curve (ROC curves ) were used to assess the platelet count/spleen diameter 
ratio cut off with the best sensitivity and specificity for a diagnosis of 
esophageal varices (cut off=909, sensitivity=100% (95% CI 100–100); 
specificity=93% (95% CI 82–98)) . The prevalence adjusted positive and 
negative predictive values for a platelet count/spleen diameter ratio 909 were 
96% and 100%, respectively. Moreover, accuracy of this platelet count/spleen 
diameter ratio cut off as evaluated by the c index was 0.981 (95% CI 0.943–
0.996). Both spleen diameter and platelet count cut offs with the best 
sensitivity and specificity for a diagnosis of esophageal varices  that were 
identified by means of ROC curves had prevalence adjusted positive and 
negative predictive values and accuracies that were lower than those of the 
platelet count/spleen diameter ratio. 
 Gianni et al (2003)(26) report that  the use of this ratio is of interest and 
is not redundant, and this hypothesis is supported by a number of both clinical 
and statistical reasons. Firstly, from a clinical point of view, platelet count 
may decrease for several reasons in patients with chronic liver disease. 
Thus the use of platelet count alone as a non-invasive predictor of 
esophageal varices can be misleading and cannot be solely attributed to portal 
hypertension. Indeed, the use of the platelet count/spleen diameter ratio 
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bypasses this possible drawback since it "normalizes" platelet count to splenic 
sequestration, most likely representing the aliquot of thrombocytopenia 
caused by portal hypertension. Secondly, from a statistical point of view, the 
platelet count/spleen diameter ratio was the only parameter independently 
associated with the presence of esophageal varices that was selected by a 
multivariate analysis which also included the single parameters. 
 The study showed that the use of the platelet count/spleen diameter 
ratio would have avoided performing unnecessary endoscopies in all patients 
with a cut off >909 without running the risk of not diagnosing esophageal 
varices. As far as cost benefit analysis is concerned, applying the "platelet 
count/spleen diameter ratio strategy" would lower the cost of esophageal 
varices screening in patients with cirrhosis. 
ASCITES (59) 
Ascites is defined as presence of free fluid within the peritoneal cavity. 
Cirrhosis is one of the commonest causes of ascites.The abnormalities 
associated with formation of ascites in patients with cirrhosis are Portal 
Hypertension, renal retention of sodium, splanchanic arterial vasodilatation, 
systemic vascular changes , increased splanchnic and hepatic lymph 
formation, hypoalbuminaemia. 
Ascites may appear suddenly when hepatocellular function is reduced, 
for instance by hemorrhage, shock, infection of an alcoholic debauch. This 
might be related to fall in serum albumin values and or intravascular fluid 
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depletion. Occlusion of the portal vein may precipitate ascites in a patient 
with a low albumin level. If the serum albumin minus ascites albumin 
gradient is greater than 1.1g/dl, it is suggestive of portal hypertension. 
Thomopolos et al(2003)(60) found out that ascites along with two other 
parameters (thrombocytopenia and splenomegaly) was an independent 
predictor of large esophageal varices in patients with cirrhosis. 
The utility of differentiating ascites into 'transudate' and 'exudate' has 
recently been challenged.   
Akriviadis et al(1996)(1)compared  the diagnostic accuracy of the 
serum/ascites albumin gradient, proposed as a new biochemical criterion for 
the differential diagnosis of ascites, with the markers traditionally used for the 
classification of peritoneal fluid into transudate and exudates. They concluded 
that the classification of ascites into transudate and exudate appears to be 
based on markers with low diagnostic accuracy. Differential diagnosis of 
ascites should be based on the serum/ascites albumin gradient, which is a 
reliable marker distinguishing ascites related to portal hypertension from all 
other causes of ascitic fluid collection, regardless of the presence of bacterial 
infection. 
According to Goyal et al (1989)(29)  Serum ascites albumin gradient, 
showed a strong correlation to portal pressure (r, + 0.83 + 0.88), and was 
found to be the best diagnostic index (with an overall accuracy of 97 per cent) 
in distinguishing the 'transudative' from 'exudative' ascites.  
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Pare et al (1983)(48) Compared  serum-ascites albumin concentration 
gradient, a parameter of oncotic pressure gradient reflecting presence or 
absence of portal hypertension, with the usual parameters of ascitic fluid 
analysis in the differential diagnosis of ascites.Authors  conclude that the 
serum-ascites albumin gradient offers the best diagnostic discrimination 
between ascites caused by liver disease and ascites caused by a neoplasm. 
SERUM ASCITES ALBUMIN CONCENTRATION GRADIENT 
(SAAG) 
The serum-ascites albumin (SAA) gradient has been defined as the 
serum albumin concentration minus the ascitic fluid albumin 
concentration.(34,59) The SAA gradient is superior to the exudate - transudate 
concept to classify ascites, being a exact portal hypertension (PH) marker. An 
elevated SAA gradient (1.1 g/L or greater) correlates with PH, whereas a low 
gradient indicates no PH. The SAA gradient correlates well with PH in 
cirrhotic patients.(2,34,59) 
Zhu et al (2003)(67)  evaluated the diagnostic value and efficacy of the 
serum-ascites albumin gradient (SAAG). SAAG demonstrates that patients 
with ascites fluid possess the basis of portal hypertension. SAAG 
classification can be considered to be a novel standard in ascites fluid 
analysis. 
Dittrich et al (2001)(19) found that  there was a significant correlation 
between the serum-ascites albumin gradient and the hepatic venous pressure 
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gradient (r = 0.502), indicating the reliability of the serum-ascites albumin 
gradient in demonstrating the presence of portal hypertension and its 
relationship with the origin of ascites. 
Torres et al (1996)(62) investigated  the association between the high 
serum-to-ascites albumin concentration gradient  with the degree and 
development of oesophageal varices, studied by endoscopy. They  also 
studied its relationship with the degree of impairment of liver function, 
determined by the Child-Pugh's score.  
The study found that the degree of high gradient of albumin  could 
discriminate patients with oesophageal varices finding like a signal of its 
presence a value of high SAAG  greater than 1.435 +/- 0.015 g/dl. It is here 
demonstrated that the degree of high SAAG does not have any relationship 
with the degree of impairment of liver function (Child-Pugh's score), 
prothrombin time, serum bilirubin, degree of encephalopathy neither grade of 
ascites. 
Gurubacharya et al (2005)(32)  studied  the correlation between the level 
of serum-ascites albumin concentration gradient (SAAG) and the 
complications of portal hypertension. 
 In patients with ascites the presence of esophageal varices is 
associated only with patients with High SAAG. The presence of esophageal 
varices  in patients with ascites and High SAAG is directly related to the 
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degree of SAAG. The size of the esophageal varices  in patients with ascites 
and High SAAG is not associated with the degree of SAAG. 
 
Torres et al (1998)(61) found that in patients with ascites the presence of 
esophageal varices  is associated only with patients with High SAAG. The 
presence of esophageal varices  in patients with ascites and High SAAG is 
directly related to the degree of SAAG. The size of esophageal varices  in 
patients with ascites and High SAAG is not associated with the degree of 
SAAG. A SAAG value of > or =1.435 +/- 0.015 g/dl is a useful means to 
predict the presence of esophageal varices  in patients with ascites. Finally, in 
patients with ascites, esophageal varices  were more prevalent in those with 
alcoholic liver disease. 
Several studies recently carried out, it was emphasized that serum-
ascites albumin gradient (SAAG) based on the difference between the 
albumin levels of serum and ascites fluid should be used to determine the 
etiology of the ascites cases instead of discrimination between transudate and 
exudate. It was shown that such a classification has a validity rate of 90% or 
more in detecting the ascites of portal hypertension. In several studies on 
cirrhosis due to alcohol, the correlation between SAAG and esophageal 
varices was emphasized and additionally, SAAG was proposed to be a factor 
determining the degree of portal hypertension and the prognosis of the 
patients in cirrhosis due to alcohol. 
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In a study performed by Hoefs et al. (1983)(35), it was shown that an 
excellent correlation exists between portal hypertension and SAAG . In this 
study, a numeric formula was established for the first time between portal 
hypertension and SAAG.While it was established in this formula that p<0.05 
and r=0.73, the numeric formula was as follows: Portal gradient=7.08 x 
[SAAG+3.62]. A similar correlation was found by Rector et al.(1984)(52) . In 
this study on patients with alcoholic cirrhosis, the correlation between 
portal hypertension and SAAG was p=0.001 and r= 0.8. In 1990, Kajani et 
al.(40) investigated the correlation in patients with alcoholic cirrhosis and with 
cirrhosis due to other causes separately . In this study, a correlation was found 
between SAAG and either portal pressure (r=0.62) or esophageal varices 
(r=0.53) in alcoholic patients.  
But in the patients with non-alcoholic cirrhosis, no correlation was 
found between SAAG and portal pressure(r=0.39), while the correlation 
between SAAG and the varix degree was found to be weaker (r=0.02). 
Although the studies performed on children yielded some common properties, 
there are remarkable differences between the results of the studies performed 
on adults versus children. In a study performed by Das et al(2001)(8) on 26 
pediatric patients with cirrhosis with primarily unknown etiologies, SAAG 
was found to be greater than 1.1 in 22 (84%) of the patients, and less than 1.1 
in the remaining four (16%) patients. While 20 (91%) of the patients with 
SAAG values greater than 1.1 had esophageal varices, 50% of the patients 
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with SAAG values less than 1.1 had varices. Although SAAG in this study 
was found to have a low specificity and sensitivity, it appeared to be a highly 
reliable guide for esophageal varices.  
In a recent study by Torres et al.(1998)(61), the correlation between 
SAAG and esophageal varices was studied. In this study, 14 patients with 
alcoholic cirrhosis were compared by their endoscopic findings and 
esophageal varices were determined in all of the patients with alcoholic 
cirrhosis. A correlation was shown between SAAG and esophageal varices in 
this study (p=0.001) 
Demyrel et al (2003)(17) study supports the observation that SAAG 
values increase in ascites due to portal hypertension. But it supports neither 
the presence nor the severity of the esophageal varices, which is another 
important finding of portal hypertension with a close correlation. It was 
remarkable that esophageal varices were present in all of the patients with an 
SAAG value greater than 2.0. Tores et al.(1998)(61) observed this in their own 
data. There was a correlation in study by Demyrel et al (2003)(17) only 
between the degree of the esophageal varices and ascites level of albumin 
(p=0.03), but the correlation co-efficient was found to be low (r=0.30). The 
fact that most of the patients reported in the literature are those patients with 
cirrhosis due to alcohol makes it difficult to interpret the results on this 
matter. Although their  data showed no linear correlation between SAAG and 
esophageal varices, it is noteworthy that 90% of the patients with non-
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alcoholic cirrhosis presenting with ascites and all of the patients with an 
SAAG value  greater than 2.0 had esophageal varices. 
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MATERIALS AND METHODS 
Type of Study: Cross sectional study. 
Sample: Liver clinic, Gastroenterology Department, and Medicine Out 
Patient Department  and In patient wards of Stanley Medical College, 
Chennai. 
Duration of study: 2005 August -  2006 July. 
INCLUSION CRITERIA 
All newly diagnosed cases of cirrhosis liver, based on physical 
examination, biochemical parameters, ultrasound abdomen and upper GI 
endoscopy. 
EXCLUSION CRITERIA 
 Present or previous history of portal hypertensive bleeding 
 Patients with hepatocellular carcinoma 
 Portal vein thrombosis 
 Previous or current treatment with β blockers, diuretics or other 
vasoactive drugs. 
 Budd Chiari Syndrome. 
INVESTIGATIONS DONE 
 Complete Hemogram 
Hemoglobin (g/dL)   MCV (fL) 
Total Count (cells/cmm)   MCHC (g/dL) 
Differential Count   PCV 
RBC (millions/cmm)  Clotting Time 
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Platelets (lakhs/cmm)  Bleeding Time 
 Liver Function Tests 
      Serum Bilirubin    Aspartate Amino Transferase 
      Serum Albumin    Alanine Amino Transferase 
      Prothrombin Time    Alkaline Phosphatase 
 Child Pugh Score 
Graded into Class A B or C 
 Ascitic Fluid Analysis 
Colour    Protein 
Total Cell Count   Differential count 
Sugar                                             SAAG 
 Ultrasound Abdomen 
Liver Surface Nodularity  Portal Vein Size 
Architecture of the liver  Splenic vein size 
Size of the liver   Spleen bipolar diameter 
Presence of ascites   Collateral circulation 
 Upper Gastrointestinal Endoscopy 
Presence of esophageal and gastric varices and grading according to 
Conns grading for esophageal varices . 
Portal Hypertensive Gastropathy 
Erosions 
Red Signs  
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PROCEDURE 
Hundred  patients with  cirrhosis liver,  attending  the medical and 
gastroenterology wards and out patient departments of Stanley Medical 
College, Chennai , between the months of August  2005 to July  2006 were 
selected, based on inclusion and exclusion criteria. 
All patients in the study underwent a full clinical evaluation .Clinical 
history and physical examination findings were recorded with particular 
attention to present or previous hematemesis, malena, bleeding per rectum, 
bleeding tendencies, alcoholism, blood transfusion, intake of hepatotoxic 
drugs, exposure to Sexually transmitted diseases, IV drug abuse, jaundice, 
anemia, edema, stigmata of chronic liver disease, dilated abdominal veins, 
ascites, splenomegaly and encephalopathy. 
All patients underwent biochemical tests, like liver function tests, 
complete blood counts, renal function tests, prothrombin time,  
ultrasonography of the abdomen to confirm the presence of cirrhosis and to 
record the spleen bipolar diameter, portal vein size, ascites and presence of 
collaterals and Ascitic fluid analysis in patients with ascites.   Upper GI 
endoscopy was done in all patients to confirm the presence of varices and also 
to grade them. 
Data were collected in a predetermined proforma  and results were 
analyzed using Software Statistical package  student version  14.0.Continuous 
variables were analyzed using t-test and categorical variables by Chi square 
test. Pearson Correlation was used to find correlation between two variables. 
Receiver operating characteristic curve was used to find the  SAAG value 
with best sensitivity and specificity for predicting esophageal varices . 
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RESULTS 
TABLE 1 : RELATIONSHIP BETWEEN AGE OF THE STUDY 
POPULATION AND GRADE OF  VARICES 
age group 
Varices 
<20 21-30 31-40 41-50 51-60 >60 
Total 
I 0 0 3 4 2 2 11 
II 3 6 9 5 7 2 32 
III 2 2 5 12 2 2 25 
IV 0 1 3 6 1 1 12 
Grade of 
varices 
0 2 2 7 6 2 1 20 
Total 7 11 27 33 14 8 100 
χ2= 16.63  P=0.67  NS 
Distribution  of grade of varices was studied in various age groups and  
no significant correlation was detected. 
Mean age of the patients in the study was 41.85. SD = 12.72 
TABLE 2 : DISTRIBUTION BASED ON SEX 
Sex 
Varices 
Male Female 
Total 
I 4 7 11 
II 19 13 32 
III 17 8 25 
IV 6 6 12 
Grade of Varices 
0 14 6 20 
Total 60 40 100 
 
χ2= 4.56  P=0.34  NS 
No significant gender difference in the distribution of grade of varices 
was found in our study. 
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TABLE 3 : DISTRIBUTION BASED ON GRADE OF VARICES 
Varices Frequency Percent 
I 11 11.0 
II 32 32.0 
III 25 25.0 
IV 12 12.0 
Grade of Varices 
0 20 20.0 
 Total 100 100.0 
 
Based on Conn’s Grading, the grading of the varices in study 
population was done. Grade II varices predominated (32 %). Varices were 
absent( Grade 0 ) in 20 % of the patients. 
TABLE 4 : RELATIONSHIP BETWEEN HEPATIC 
ENCEPHALOPATHY AND VARICES 
Hepatic       Encephalopathy 
Varices 
yes no 
Total 
I 1 10 11 
II 2 30 32 
III 4 21 25 
IV 3 9 12 
Grade of Varices 
0 0 20 20 
Total 10 90 100 
 
χ2= 6.70  P=0.15  NS 
No significant relation between presence of hepatic encephalopathy 
and grade of varices was found. 
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TABLE 5 :RELATIONSHIP BETWEEN CHILD PUGH GRADE AND 
VARICES 
Varices CP grade Total 
 1 2 3  
I 5 5 1 11 
II 4 21 7 32 
III 0 16 9 25 
IV 0 4 8 12 
Grade of Varices 
0 3 16 1 20 
Total 12 62 26 100 
χ2= 31.5  P=0.001  S 
Patients were grouped according to Child Pugh Classification of 
Cirrhosis. The relationship between Child Pugh Grade and the grade of 
varices was studied and significant correlation noted( P=0.001). 
TABLE 6 : RELATIONSHIP BETWEEN LAB PARAMETERS  AND 
PRESENCE OF VARICES 
Parameter Varices N Mean Std. Deviation Student t-test 
Present 80 2.371 2.1985 
Absent 20 1.765 1.7358 
Serum Bilirubin 
 
 Total 100 2.250 2.1200 
t=1.3 
P=0.25 
Present 80 2.83 .739 
Absent 20 2.84 .670 
Serum Albumin 
 
 Total 100 2.83 .723 
t=0.01 
P=0.98 
Present 80 9.291 2.8257 
Absent 20 8.345 2.8115 
Hemoglobin 
 
 Total 100 9.102 2.8343 
t=1.8 
P=0.18 
Present 80 96425.00 49847.051 
Absent 20 149600.00 89073.240 Platelet Count 
Total 100 107060.00 62947.921 
t=12.8 
P=0.001 
Present 80 171.61 40.988 
Absent 20 146.45 29.009 Spleen Bipolar Diameter Total 100 166.58 40.055 
t=6.6 
P=0.01 
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 Relationship between non invasive parameters like Serum Bilirubin, 
Serum albumin, Hemoglobin, Platelet count, spleen Bipolar diameter  to  
resence of  varices was studied. Of this only Platelet Count (P=0.001) and 
Spleen Bipolar diameter (P=0.01) had statistical significance. 
TABLE 7: RELATIONSHIP BETWEEN PORTAL VEIN SIZE AND 
PRESENCE OF VARICES 
Parameter Varices N Mean 
Std. 
Deviation 
Student 
t-test 
Present 80 14.091 4.4062 Portal Vein 
Size Absent 20 12.230 3.4576 
t=2.03 
P=0.05 
 
Significance was  noted between Portal vein size(cm) and presence of 
Varices in the study group. 
TABLE 8 : ASSOCIATION BETWEEN PC/SD RATIO AND 
PRESENCE OF VARICES 
  Varices 
PC/SD ratio Pearson Correlation -.482(**) 
 Sig. (2-tailed) .000 
 N 100 
 
**  Correlation is significant at the 0.01 level (2-tailed). 
There was  statistically significant  correlation between presence of 
varices and a platelet count/ splenic bipolar diameter ratio  of  ≤ 909. 
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0-0.2   poor correlation,0.2-0.4 fair,0.4-0.6 moderate,0.6-0.8 good, 0.8-
1.0 Very good. 
TABLE 9 : RELATIONSHIP BETWEEN PC/SD RATIO AND GRADE 
OF VARICES 
 
PC/SD RATIO Total 
 
≤909 >909  
I 11 0 11 
II 28 4 32 
III 23 2 25 
IV 12 0 12 
Grade of Varices 
0 10 10 20 
Total 84 16 100 
 
χ2= 23.1  P=0.001  S 
Patients were categorized in to two groups based on cut off value of 
909 for Platelet count / splenic diameter ratio. It’s relation to the grade of 
varices was studied. A significant difference between the presence or absence 
of esophageal varices and platelet count to spleen diameter ratio  of ≤909 was 
observed. 
 
 53
TABLE 10 : RELATIONSHIP BETWEEN ASCITES AND PRESENCE 
OF VARICES 
 
Ascites 
No Yes Varices 
n % n % 
Present 53 82.8% 27 75.0% 
Varices 
Absent 11 17.2% 9 25.0% 
 
χ2= 0.88  P=0.35 NS 
No significant association was obtained between presence of ascites 
and presence of varices in the study population. 
TABLE 11 : RELATIONSHIP BETWEEN ASCITES AND GRADE OF 
VARICES 
Ascites 
 
no yes 
Total 
I 7 4 11 
II 24 8 32 
III 13 12 25 
IV 9 3 12 
Grade of Varices 
0 11 9 20 
Total 64 36 100 
χ2= 4.57  P=0.33 NS 
No significant association was noted between presence of ascites and 
grade of varices in our study group. 
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TABLE 12 : DISRTBUTION BASED ON SAAG VALUES 
SAAG Frequency Percent 
<1.1 14 38.9 
1.1-1.44 9 25 
1.45-1.99 11 30.6 
>2 2 5.6 
Total 36  
 
38.9 % of the patients had Serum ascetic albumin gradient ( SAAG) < 1.1g/dl 
SAAG > 1.1g/dl was seen in 61.1 % of the patients. 
TABLE 13 : RELATIONSHIP BETWEEN SAAG AND PRESENCE OF 
VARICES 
SAAG g/dl Varices 
 Present Absent 
 n % n % 
<1.1 5 18.5% 9 100.0% 
>1.1 22 81.5% 0  
 
χ2= 10.86  P=0.001  S 
81 % 0f the study population had varices when SAAG value was more 
than 1.1g/dl 
All the patients in whom varices were absent had SAAG values less 
than 1.1g/dl.The two groups showed statistically significant difference ( P= 
0.001) based on presence and absence of varices. 
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TABLE 14: RELATIONSHIP BETWEEN SAAG AND GRADE OF 
VARICES 
 
SAAG VALUES Grade of Varices Total 
 I II III IV 0  
SAAG <1.1 1 4 0 0 9 14 
g/dl 1.1-1.44 1 2 5 1 0 9 
 1.45-1.99 2 1 6 2 0 11 
 >2 0 1 1 0 0 2 
Total 4 8 12 3 9 36 
 
When the Value of SAAG was < 1.1g/dl it was noted that Grade III 
and IV varices were absent. When the SAAG values increased more than 
1.1g/dl, there was considerable increase in grade III varices. 
TABLE 15 : ASSOCIATION BETWEEN SAAG AND GRADE OF 
VARICES 
   Varices 
SAAG Pearson Correlation 0..552(**)
  Sig. (2-tailed) .000
  N 36
 
**  Correlation is significant at the 0.01 level (2-tailed). 
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TABLE 16 : COORDINATES OF THE CURVE (ROC) 
Test Result Variable(s): SAAG 
Positive if Greater Than or Equal To(a) Sensitivity 1 - Specificity 
-.2000 1.000 1.000 
.8500 .963 1.000 
.9500 .889 .778 
1.0500 .815 .333 
1.1500 .815 .000 
1.2500 .778 .000 
1.3500 .667 .000 
1.4500 .481 .000 
1.5500 .407 .000 
1.6500 .296 .000 
1.7500 .222 .000 
1.8500 .111 .000 
1.9500 .074 .000 
3.0000 .000 .000 
 
The test result variable(s): SAAG has at least one tie between the 
positive actual state group and the negative actual state group. 
a=  The smallest cutoff value is the minimum observed test value 
minus 1, and the largest cutoff value is the maximum observed test value plus 
1. All the other cutoff values are the averages of two consecutive ordered 
observed test values. 
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When cut off SAAG value was taken as 1.20± .05 gm/dl it was noted 
that the test achieved 100 % specificity and sensitivity ranging from 77.8 to 
81.5 %. 
TABLE 17 : ROLE OF PC/SD RATIO IN PREDICTING VARICES 
  
 Varices Total 
 Present Absent  
PC/SD RATIO ≤909 74 10 84 
 >909 6 10 16 
Total 80 20 100 
 
 Value in % 95 % CI 
Sensitivity 88 79-94 
Specificity 63 35-85 
False positive 38 15-65 
False Negative 12 6-21 
Positive Predictive Value 93 84-97 
Negative Predictive Value 50 27-73 
 
The sensitivity of PC/SD Ratio of ≤ 909  in predicting  presence of 
esophageal varices was 88 %. It’s positive predictive value is 93 %. 
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TABLE 18 : ROLE OF SAAG IN PREDICTING VARICES IN 
CIRRHOTIC PATIENTS WITH ASCITES 
 
Varices 
 
Present Absent 
Total 
< 1.1 5 9 22 
SAAG 
> 1.1 22 0 14 
Total 27 9 36 
 
 Value in % 95 % CI 
Sensitivity 81 62-94 
Specificity 100 63-100 
False positive 0 0-33 
False Negative 19 6-38 
Positive Predictive Value 100 85-100 
Negative Predictive Value 64 35-87 
 
The sensitivity of  SAAG  > 1.1 in predicting the presence of  varices  
is 81 % and  it’s positive predictive value is 100 %. 
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TABLE 19 : UTILTY OF COMBINING SAAG AND PC/SD RATIO AS 
NON INVASIVE PARAMETERS FOR PREDICTING VARICES IN 
CIRRHOTIC PATIENTS WITH ASCITES 
PC/SD RATIO 
 ≤909 >909 Total 
<1.1 11 3 14  
SAAG >1.1 20 2 22
Total 31 5 36
 
Parameter 
Number of patients 
with Varices detected
Percentage 
detected 
SAAG 22/36 61 % 
SAAG AND PC/SD RATIO 20/31 66 % 
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DISCUSSION 
Our study sample consisted of hundred patients of whom sixty were 
male and forty were females. The mean age was 41.85 (SD = 12.72 ). 
Distribution of grade of varices was studied in various age groups and  no 
significant correlation was detected.(Table 1) 
No significant gender difference in the distribution of grade of varices 
was found in our study.( Table 2).  
We studied the frequency of distribution based on Conn’s grading of 
varices and found that Grade II predominated (32 %). 20 % of the study 
population did not have varices.(Table 3; Figure 1). 
Our study could not find any significant association between hepatic 
encephalopathy and varices.( Table 4). 
Patients were grouped according to Child Pugh Classification of 
Cirrhosis. The relationship between Child Pugh Grade and the grade of 
varices was studied and significant correlation noted (P=0.001) (Table 5, 
Figure 2). Thus as patients progress to decompensated liver disease ( CP 
Grade B & C) it is noted that the presence of varices increases.This is finding 
is consistent with  study by Madhotra et al(2002),Zaman et al (2001). 
Relationship between non invasive parameters like Serum Bilirubin, 
Serum albumin, Hemoglobin, Platelet count, spleen Bipolar diameter to 
presence of varices was studied. Among these only Platelet Count (P=0.001) 
and Spleen Bipolar diameter (P=0.01) had statistical significance. (Table 6) 
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 The results indicating the relevance of platelet count are on par with 
studies by Thomopolos et al (2003), Madhotra et al (2002), Pilette et al 
(1999), Shepis et al(1999), Zaman et al (1999).Studies by Chalasani et 
al(1999), Sanjay Kumar et al (2006),Torres et al (1996) state that 
splenomegaly  is an independent predictor of presence of varices. 
Significance was noted between portal vein size (cm) and presence of 
varices. (Table 7) 
Similar results were obtained in study by D’Amico et al (2004). 
Patients were categorized in to two groups based on cut off value of 
909 for Platelet count / splenic diameter ratio. It’s relation to the grade of 
varices was studied. A significant difference between the presence or absence 
of esophageal varices and platelet count to spleen diameter ratio  of 909 was 
observed. (P= 0.001) ( Table 8,9)( Figure 3,4). This finding is in agreement 
with study by Gianni et al(2003). The use of Platelet count/ splenic diameter 
ratio overcomes the fallacy of using Platelet count alone in predicting 
esophageal varices for the reason that platelet count may decrease in chronic 
liver disease due to several other factors. This ratio is  introduced to take in to 
consideration the decrease in platelet count which most likely depends on 
hypersplenism caused by portal hypertension. Performing unnecessary 
endoscopy in all patients can be avoided if we take a platelet count/ splenic 
diameter ratio cut off > 909, without running the risk of missing cases with 
esophageal varices . 
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Although Thomopolos et al (2003) have put forth ascites  as an 
independent predictor of presence of large  varices, our study does not 
demonstrate a statistically correlation between presence and grade of varices 
and ascites.(Table 10,11) 
We grouped patients based on range of SAAG values. Of the study 
sample SAAG was less than 1.1 in 38.9 % of the patients and more than 1.1 in 
61.1 %.(Table 12) 
81 % 0f the study population had varices when SAAG value was more 
than 1.1 
All the patients in whom varices were absent had SAAG values less 
than 1.1 
The two groups showed statistically significant difference ( P= 0.001) 
based on presence and absence of varices. (Table 13; figure 5 a & b). This is 
consistent with studies by Torres et al(1996), Gurubacharya et al 
(2005),Kajani et al(1990), Dittrich et al (2001). 
We also assessed the correlation between grade of varices and SAAG 
values.( Table 14,15)(Figure 6 a & b)When the Value of SAAG was < 1.1 it 
was noted that Grade III and IV varices were absent. When the SAAG values 
increased more than 1.1, there was considerable increase in grade III varices.. 
In our study there was moderate correlation (r= 0.552) between SAAG and 
grade of varices. This finding is similar to the study by Torres et 
al(1996,1998).  However,  Gurubacharya et al(2005) and Demyrel et al (2003) 
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did not find out any correlation between degree of SAAG and grade of 
varices. 
Receiver operating characteristic curve (ROC curves ) (Figure 7)were 
used to assess the cut off value of SAAG with the best sensitivity and 
specificity for a diagnosis of esophageal varices. We found that when the cut 
off value of SAAG was taken as  
1.20± .05 gm/dl it was noted that the test achieved 100 % specificity 
and sensitivity ranging from 77.8 to 81.5 %.   
However Torres et al (1998) found that a SAAG value of more than or 
equal to 1.435±.015 gm/dl is a useful mean to predict the presence of 
esophageal varices  in patients with ascites. 
The sensitivity of PC/SD Ratio of ≤909  in predicting  presence of 
esophageal varices was 88 % with  95 % CI  79-94%  It’s positive predictive 
value is 93 % with 95 % CI  84-97%  (Table 17) However study by  Gianni et 
al(2003) brought out a sensitivity of 100 % and specificity of 93 % if Platelet 
count /Splenic diameter ratio was used in predicting varices. Even though, in 
our study the sensitivity of the ratio was only 88%, it would still be a very 
good tool for screening since we cater to a bigger patient population and have 
restricted resources. Since Cirrhotic patients need regular follow up with 
repeated endoscopies, using PC/SD ratio cut off of 909 would help reduce the 
burden. 
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The sensitivity of  SAAG  > 1.1g/dl  in predicting the presence of  
varices in the subgroup of patients with ascites   was  81 %(95% CI; 62-94) 
and  it’s positive predictive value is 100 % (95 %CI 85 – 100).(Table 18) . 
In the subgroup of 36 patients with ascites we attempted to combine 
the parameters 
( SAAG > 1.1 and Platelet count/Splenic diameter ratio cut off ≤ 909) 
.We found that if only SAAG was taken in to account, varices were diagnosed 
in 61 % of the study group. If Platelet count/ Splenic diameter ratio cut off of 
≤ 909 was also applied, varices were diagnosed in 66 %. Combining these two 
non invasive parameters  in  subgroup with ascites can increase the reliability 
of predicting esophageal varices.  So these parameters can be used to 
regularly follow up the cirrhotic patients with ascites for the progression of 
grade of varices at appropriate intervals. 
Thus use of these parameters may help identify patients with a low 
probability of esophageal varices  who may not need endoscopy. This may 
help reduce costs and discomfort for these patients and the burden on 
endoscopy units. 
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SUMMARY AND CONCLUSIONS 
Hundred  patients with newly diagnosed   cirrhosis  without  prior 
history of bleed were subjected to  clinical evaluation. All patients underwent 
biochemical tests, like liver function tests, complete blood counts, renal 
function tests, prothrombin time,  ultrasonography of the abdomen to confirm 
the presence of cirrhosis and to record the spleen bipolar diameter, portal vein 
size, ascites and presence of collaterals and Ascitic fluid analysis in patients 
with ascites  . Upper GI endoscopy was done in all patients to confirm the 
presence of varices and also to grade them. We tried to identify non invasive 
parameters for predicting esophageal varices  in Cirrhotic patients. We 
assessed the role of  Platelet count/Splenic diameter ratio and SAAG  for 
predicting esophageal varices  in cirrhotic patients. 
Presence of varices increases as patients progress to decompensated 
liver disease.( Child Pugh grade B & C ). 
Decrease in platelet count was  found to be an predictor of esophageal 
varices  in patients with cirrhosis. 
Ultrasound parameters Spleen bipolar diameter and portal vein size 
also predict the presence of esophageal varices . 
When a cut off value  of Platelet count/ splenic diameter ratio of ≤ 909 
was applied in order to take in to consideration the decrease in platelet count 
due to hypersplenism; it was found to be a good predictor of presence and 
grade of esophageal varices . 
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The sensitivity of PC/SD Ratio of ≤909  in predicting  presence of 
esophageal varices was 88 % with   it’s positive predictive value was 93 %. 
Value of Serum ascitic albumin gradient (SAAG) more than 1.1g/dl  is 
found to be a predictor for presence and grade of esophageal varices . 
The sensitivity of  SAAG  > 1.1g/dl  in predicting the presence of  
varices in the subgroup of patients with ascites   was  81 %and  it’s positive 
predictive value was100 %. 
When the  cut off value of SAAG was taken as 1.20± .05 gm/dl it was 
noted that the test achieved 100 % specificity and sensitivity ranging from 
77.8 to 81.5 %.  
 If only SAAG was taken in to account, varices were diagnosed in 61 
% of the cirrhotic patients with ascites. When Platelet count/ Splenic diameter 
ratio cut off of ≤ 909 was also applied, varices were diagnosed in 66 %. 
Combining these two non invasive parameters  in  subgroup with 
ascites can increase the reliability of predicting esophageal varices.So these 
parameters can be used to regularly follow up the cirrhotic patients with 
ascites for the progression of grade of varices at specific  intervals. 
The use of Platelet count/ Splenic diameter ratio, SAAG and 
combination of these two non invasive parameters in appropriate subgroups of 
cirrhotic patients for screening and follow up of esophageal varices  can 
substantially reduce the  cost of health care and discomfort for patients as well  
as reduce burden on endoscopy units. 
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LIMITATIONS 
1.  Small sample size. 
2.  Prospective studies were not done to validate the role of predictive 
parameters. 
3.  Although we could show that combining the two non invasive 
parameters increased the percentage of varices being detected, the 
combined sensitivity could not be calculated because of inadequate 
sample size. 
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VARICES 
 
 
 
 
 
 
 
 
 
 
 
GRADING OF VARICES
G2
32%
G4
12%
G0
20%
G1
11%
G3
25%
G1
G2
G3
G4
G0
0
5
10
15
20
25
N
o.
 o
f p
at
ie
nt
s
1 2 3
CP Grade and Grade of Varices
G1
G2
G3
G4
G0
FIGURE 3:CORRELATION BETWEEN GRADE OF VARICES AND 
PC/SD  RATIO 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 4: RELATIONSHIP BETWEEN PC/SD RATIO AND GRADE OF 
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